Relay Therapeutics

RLAY · NASDAQ

$18.45+$1.36 (+7.96%)TodayMarket closed ·
Prev close $17.09

Who owns RLAY

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 61.2% of RLAY’s shares.

  • SB Investment Advisers (UK) Limited12.9%
  • Fidelity Management & Research Company LLC7.6%
  • Casdin Capital, LLC7.4%
  • Perceptive Advisors LLC6.5%
  • Next 6 largest institutions26.7%
  • All other shareholders38.8%
Top institutional holders of RLAY
HolderShares% of shares
SB Investment Advisers (UK) Limited27.90M12.95%
Fidelity Management & Research Company LLC16.34M7.58%
Casdin Capital, LLC16.04M7.44%
Perceptive Advisors LLC14.11M6.54%
BlackRock Institutional Trust Company, N.A.12.33M5.72%
Commodore Capital LP12.00M5.57%
State Street Investment Management (US)10.13M4.70%
Vanguard Capital Management, LLC8.96M4.16%
T. Rowe Price Associates, Inc.7.44M3.45%
Nextech Invest, Ltd.6.78M3.14%

Largest mutual fund holders

Top mutual fund holders of RLAY
HolderShares% of shares
BB Biotech Fd8.23M3.82%
Vanguard Total Stock Market Index Fund6.83M3.17%
State Street SPDR S&P Biotech ETF6.64M3.08%
iShares Russell 2000 ETF4.20M1.95%
Fidelity Select Health Care Portfolio2.08M0.96%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $127.94M (26 trades) of RLAY on the open market, with no buys.

Latest RLAY insider transactions
InsiderTypeSharesValue
Patel SanjivSale48.20K$872.40K
Catinazzo ThomasSale206$3.97K
Catinazzo ThomasSale17.51K$325.35K
Catinazzo ThomasSale17.72K$335.56K
Patel SanjivSale48.20K$912.89K
Bergstrom Donald ASale8.53K$161.81K
Rahmer PeterSale4.51K$90.30K
SVF Pauling (Cayman) LtdSale6.00M$116.40M
Patel SanjivSale48.20K$979.89K
Catinazzo ThomasSale17.72K$349.73K

Short interest

Settled Sep 30, 2026

Shares short
46.75M
Days to cover
12.59
% of shares outstanding
21.69%
Average daily volume
3.71M
Change since last report
+5.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.